Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global GMP Plasmid DNA Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global GMP Plasmid DNA Market Status and Forecast (2016-2027)
      • 1.3.2 Global GMP Plasmid DNA Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global GMP Plasmid DNA Supply by Company

    • 2.1 Global GMP Plasmid DNA Sales Value by Company
    • 2.2 GMP Plasmid DNA Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional GMP Plasmid DNA Market Status by Category

    • 3.1 GMP Plasmid DNA Category Introduction
      • 3.1.1 Standard
      • 3.1.2 Ultra-Pure
    • 3.2 Global GMP Plasmid DNA Market by Category
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional GMP Plasmid DNA Market Status by End User/Segment

    • 4.1 GMP Plasmid DNA Segment by End User/Segment
      • 4.1.1 DNA Vaccines
      • 4.1.2 Gene Therapy
      • 4.1.3 Immunotherapy
      • 4.1.4 Others
    • 4.2 Global GMP Plasmid DNA Market by End User/Segment
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global GMP Plasmid DNA Market Status by Region

    • 5.1 Global GMP Plasmid DNA Market by Region
    • 5.2 North America GMP Plasmid DNA Market Status
    • 5.3 Europe GMP Plasmid DNA Market Status
    • 5.4 Asia Pacific GMP Plasmid DNA Market Status
    • 5.5 Central & South America GMP Plasmid DNA Market Status
    • 5.6 Middle East & Africa GMP Plasmid DNA Market Status

    6 North America GMP Plasmid DNA Market Status

    • 6.1 North America GMP Plasmid DNA Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe GMP Plasmid DNA Market Status

    • 7.1 Europe GMP Plasmid DNA Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific GMP Plasmid DNA Market Status

    • 8.1 Asia Pacific GMP Plasmid DNA Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America GMP Plasmid DNA Market Status

    • 9.1 Central & South America GMP Plasmid DNA Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa GMP Plasmid DNA Market Status

    • 10.1 Middle East & Africa GMP Plasmid DNA Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Major Downstream Customers Analysis

    • 11.1 Customer One Analysis
    • 11.2 Customer Two Analysis
    • 11.3 Customer Three Analysis
    • 11.4 Customer Four Analysis

    12 Global GMP Plasmid DNA Market Forecast by Category and by End User/Segment

    • 12.1 Global GMP Plasmid DNA Sales Value Forecast (2022-2027)
    • 12.2 Global GMP Plasmid DNA Forecast by Category
    • 12.3 Global GMP Plasmid DNA Forecast by End User/Segment

    13 Global GMP Plasmid DNA Market Forecast by Region/Country

    • 13.1 Global GMP Plasmid DNA Market Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Waisman Biomanufacturing
      • 14.1.1 Company Information
      • 14.1.2 GMP Plasmid DNA Product Introduction
      • 14.1.3 Waisman Biomanufacturing GMP Plasmid DNA Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 VGXI
      • 14.2.1 Company Information
      • 14.2.2 GMP Plasmid DNA Product Introduction
      • 14.2.3 VGXI GMP Plasmid DNA Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 PlasmidFactory
      • 14.3.1 Company Information
      • 14.3.2 GMP Plasmid DNA Product Introduction
      • 14.3.3 PlasmidFactory GMP Plasmid DNA Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Nature Technology Corporation
      • 14.4.1 Company Information
      • 14.4.2 GMP Plasmid DNA Product Introduction
      • 14.4.3 Nature Technology Corporation GMP Plasmid DNA Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 LakePharma
      • 14.5.1 Company Information
      • 14.5.2 GMP Plasmid DNA Product Introduction
      • 14.5.3 LakePharma GMP Plasmid DNA Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Kaneka
      • 14.6.1 Company Information
      • 14.6.2 GMP Plasmid DNA Product Introduction
      • 14.6.3 Kaneka GMP Plasmid DNA Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Gedeon Richter
      • 14.7.1 Company Information
      • 14.7.2 GMP Plasmid DNA Product Introduction
      • 14.7.3 Gedeon Richter GMP Plasmid DNA Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Eurogentec
      • 14.8.1 Company Information
      • 14.8.2 GMP Plasmid DNA Product Introduction
      • 14.8.3 Eurogentec GMP Plasmid DNA Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Delphi Genetics
      • 14.9.1 Company Information
      • 14.9.2 GMP Plasmid DNA Product Introduction
      • 14.9.3 Delphi Genetics GMP Plasmid DNA Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 Cobra Bio
      • 14.10.1 Company Information
      • 14.10.2 GMP Plasmid DNA Product Introduction
      • 14.10.3 Cobra Bio GMP Plasmid DNA Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.10.4 SWOT Analysis

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global GMP Plasmid DNA market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global GMP Plasmid DNA market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Standard
      Ultra-Pure

      Segmented by End User/Segment
      DNA Vaccines
      Gene Therapy
      Immunotherapy
      Others

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Waisman Biomanufacturing
      VGXI
      PlasmidFactory
      Nature Technology Corporation
      LakePharma
      Kaneka
      Gedeon Richter
      Eurogentec
      Delphi Genetics
      Cobra Bio
      Buy now